Head Neck
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Magrolimab and Cetuximab With Pembrolizumab or Docetaxel for Recurrent/Metastatic Head Neck Squamous Cell Carcinoma (NCT06046482) | M.D. Anderson Cancer Center | 2023-11-28 |
Track Head Neck automatically
Every clearance here is in the API, with alerts when new ones post.